Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy

Area of Science:

• Infectious Diseases
• Cardiology
• Pharmacology

Background:

• Staphylococcus aureus endocarditis is a serious infection, particularly in intravenous drug abusers.
• Traditional treatment regimens for endocarditis are often lengthy.
• Short-course antibiotic regimens are being explored to improve patient outcomes and reduce treatment burden.

Purpose of the Study:

• To evaluate the efficacy of short-course combination antibiotic therapy for Staphylococcus aureus endocarditis.
• To compare nafcillin plus tobramycin with vancomycin plus tobramycin in a selected patient population.

Main Methods:

• An open-label study was conducted with 53 intravenous drug abusers.
• Patients had relatively uncomplicated right-sided S. aureus endocarditis.
• Treatment involved a 2-week course of nafcillin and tobramycin or vancomycin and tobramycin.

Main Results:

• The nafcillin and tobramycin combination achieved a cure rate of 94% (47/50 patients).
• The vancomycin and tobramycin regimen had a cure rate of 33% (1/3 patients).
• No significant adverse events were reported for the short-course regimens.

Conclusions:

• A 2-week regimen of nafcillin plus tobramycin is a safe and effective treatment for selected patients with S. aureus endocarditis.
• Vancomycin plus tobramycin showed limited efficacy in this small cohort.
• Further research is needed to confirm the efficacy of vancomycin-based regimens.